What is Pulmonary Atresia?   September 11, 2008

The use of Paxil by mothers during the first trimester of pregnancy increases the risks of congenital heart abnormalities in newborns. One of the most serious abnormalities that can occur is pulmonary atresia. In infants born with pulmonary atresia, no pulmonary valve exists. This prevents the flow of blood from the right ventricle into the pulmonary artery and then to the lungs. Continue reading ⇒

Federal Digitek Suits Consolidated to West Virginia in MDL 1968   September 9, 2008

The United States Judicial Panel on Multidistrict Litigation has issued and order consolidating all federal lawsuits related to defective, double strength Digitek (commonly known as Digitalis or Digoxin ) to the U.S. District Court for the Southern District of West Virginia.  Continue reading ⇒

In: Tags:
TNF Antogonist Linked To Potentially Fatal Fungal Infections and Cancer   September 7, 2008

The FDA has ordered stronger warnings for four drugs used to treat rheumatoid arthritis. The FDA warns that patients are at risk of developing potentially fatal fungal infections. Continue reading ⇒

In: Tags:
Arthritis Drugs Linked to Deadly Fungal Infections and Cancers   September 7, 2008

The FDA has ordered stronger warnings for four drugs used to treat rheumatoid arthritis. The FDA warns that patients are at risk of developing potentially fatal fungal infections. Continue reading ⇒

In: Tags:
FDA IS URGED TO PULL ORTHO EVRA   May 8, 2008

Ortho Evra is again under attack because of its increased risks of serious blood clots, pulmonary embolism, deep vein thrombosis and death among young women who use the product.

Reuters is reporting that Public Citizen's Helath Research Group has filed a petition with the FDA urging them to remove Johson & Johnson's Ortho Evra birth control patch from the market.  Continue reading ⇒

Important Update - Pre-Emption   February 22, 2008

On February 20, 2008 the United States Supreme Court in a decision written by Justice Scalia, Estate of Rigel v. Continue reading ⇒

Actavis Recalls Certain Fentanyl Patches in the US as Precaution   February 19, 2008

FOR IMMEDIATE RELEASE -- Morristown, NJ -- February 17, 2008 -- Actavis Inc., the United States manufacturing and marketing division of the international generic pharmaceutical company Actavis Group hf, today announced that 14 lots of Fentanyl transdermal system CII patches sold in the United States by Actavis' subsidiary Actavis South Atlantic LLC are being voluntarily r Continue reading ⇒

In: Tags:
FDA ADVISORY - FEBRUARY 15, 2008   February 16, 2008
Duragesic 25 mcg/hr (fentanyl transdermal system) CII Pain Patches
Audience: Pain management specialists, other healthcare professionals, patients [Posted 02/15/2008] PriCara and Sandoz Inc. announced a nationwide recall of all lots of 25 mcg/hr Duragesic Patches sold in the United States.
Continue reading ⇒
Asbestos - Help For Mesothelioma Victims   February 14, 2008

Our affiliated asbestos attorneys aggressively seek to protect the rights and obtain financial recoveries for the victims of Asbestos exposure particularly those suffering from mesothelioma. Mesothelioma is a rare lung cancer caused by exposure to asbestos. If you or your loved one has been diagnosed with mesothelioma it is more likely than not to have been caused by exposure to asbestos. Continue reading ⇒

In: Tags:
Plans To Boost Sales Despite Continued Safety Concerns Surrounding Avandia   February 12, 2008

The slumping sales of Avandia have seriously impacted the profitability of GlaxoSmithKline (GSK). Wall Street analysts have downgraded the stock amid rising concerns of impending litigation involving Avandia and Paxil and increased generic competition that will continue to erode GSK's market share. Continue reading ⇒

Lawsuits of Interest

Zelnorm
Zometa
Fill out this form for a free evaluation:
Please type your name.
Please type your email address.
Please select the cause of your injury.
Enter any information that you would lke us to know.